Common side effects of Firazyr include: hematoma at injection site, injection site reaction, urticaria at injection site, bruising at injection site, burning sensation at injection site, erythema at injection site, irritation at injection site, pain at injection site, and swelling at injection site.  See below for a comprehensive list of adverse effects.
The most common adverse reactions were injection site reactions, pyrexia, transaminase increased, dizziness, and rash.
Injection site reaction includes bruising, hematoma, burning, erythema, hypoesthesia, irritation, numbness, edema, pain, pressure sensation, pruritus, swelling, urticaria, or warmth at the site of injection.
Very common (10% or more): Injection site reaction (97%)
Common (1% to 10%): Rash, pruritus, erythemaUncommon (0.1% to 1%): Generalized urticaria
Common (1% to 10%): Nasopharyngitis, nasal congestionUncommon (0.1% to 1%): Pharyngitis, asthma, cough
Common (1% to 10%): Gastroenteritis, nauseaUncommon (0.1% to 1%): Vomiting
Common (1% to 10%): Dizziness, headache
Common (1% to 10%): PyrexiaUncommon (0.1% to 1%): Asthenia, fatigue, contusion
Common (1% to 10%): Transaminase increasedUncommon (0.1% to 1%): Liver function test abnormal
Common (1% to 10%): Prothrombin time prolonged
Common (1% to 10%): Blood creatinine phosphokinase increased
Uncommon (0.1% to 1%): Weight increased, blood glucose increased, hyperuricemia, hyperglycemia
Uncommon (0.1% to 1%): Herpes zosterFrequency not reported: Anti-icatibant (the active ingredient contained in Firazyr) antibodies
Uncommon (0.1% to 1%): Hot flush
Uncommon (0.1% to 1%): Proteinuria
Uncommon (0.1% to 1%): Muscle spasm
Fever
Bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site
Dizziness
Headache
nausea
rash